Drug product
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
D-0251-2026
Product summary
- Event
- Event 98181
- Status
- Ongoing
- Classification
- Class II
- Quantity
- 314 boxes of 6,280 pre-filled syringes
- Official record key
drug-enforcement:D-0251-2026
Official wording
Reason: Presence of particulate matter - Glass like particles.
Code information: Lot: 25JAN033A, 25JAN033B, Expires: 02/12/2026.
Distribution pattern: U.S Nationwide
Derived failure modes
-
Foreign material or chemical contamination
particulate matter